Company / Operating Income
MEDICINOVA INC Operating Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$13.3M
FY2025
5-year range
-$14.6M / -$9.9M
FY2021-FY2025
Trend
-34.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$15M to -$13M over the past 2 years.
Based on SEC 10-K filings.
-$13M in FY2025.
Improved from -$15M to -$13M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 34.2% year-over-year.
- Peak operating income was recorded in FY2014.
- Lowest operating income in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.3M | -34.2% |
| FY2024 | -$9.9M | +32.3% |
| FY2023 | -$14.6M | +0.0% |
| FY2022 | -$14.6M | -43.2% |
| FY2021 | -$10.2M | -10.8% |
| FY2014 | -$9.2M | +15.7% |
| FY2013 | -$10.9M | +32.1% |
| FY2012 | -$16.1M | +0.0% |
| FY2011 | -$16.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026